HUP0204091A2 - Eljárások a clarithromycin polimorf módosulatainak előállítására és az új polimorf IV módosulat, és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents

Eljárások a clarithromycin polimorf módosulatainak előállítására és az új polimorf IV módosulat, és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk

Info

Publication number
HUP0204091A2
HUP0204091A2 HU0204091A HUP0204091A HUP0204091A2 HU P0204091 A2 HUP0204091 A2 HU P0204091A2 HU 0204091 A HU0204091 A HU 0204091A HU P0204091 A HUP0204091 A HU P0204091A HU P0204091 A2 HUP0204091 A2 HU P0204091A2
Authority
HU
Hungary
Prior art keywords
clarithromycin
processes
pharmaceutical composition
composition containing
novel polymorph
Prior art date
Application number
HU0204091A
Other languages
English (en)
Inventor
Ilya Avrutov
Ronen Borochovitz
Igor Lifshitz
Basem Masarva
Edi Schwartz
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of HUP0204091A2 publication Critical patent/HUP0204091A2/hu
Publication of HUP0204091A3 publication Critical patent/HUP0204091A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya clarithromycin 0 forma átalakítására vonatkozóeljárások, clarithromycin II formává, amelyek magukban foglalják aclarithromycin 0 forma szuszpendálását vízben. A találmány tárgyatovábbá a clarithromycin II forma előállítása erythromycin Aátalakításával clarithromycinné, ezt követően a clarithromycin 0 formaclarithromycin II formává alakítása szuszpendálással. A találmánytárgya továbbá a clarithromyycin IV forma, és annak előállításaieljárása, a vegyületet tartalmazó gyógyszerkészítmények, és módszer avegyület terápiás szerként történő felhasználására. Ó
HU0204091A 1999-12-16 2000-12-15 Processes for preparing clarithromycin polymorphs and novel polymorph iv and pharmaceutical composition containing them and their use HUP0204091A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17122199P 1999-12-16 1999-12-16
US17183999P 1999-12-22 1999-12-22
PCT/US2000/033845 WO2001044262A1 (en) 1999-12-16 2000-12-15 Processes for preparing clarithromycin polymorphs and novel polymorph iv

Publications (2)

Publication Number Publication Date
HUP0204091A2 true HUP0204091A2 (hu) 2003-04-28
HUP0204091A3 HUP0204091A3 (en) 2003-05-28

Family

ID=26866853

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204091A HUP0204091A3 (en) 1999-12-16 2000-12-15 Processes for preparing clarithromycin polymorphs and novel polymorph iv and pharmaceutical composition containing them and their use

Country Status (20)

Country Link
US (2) US6599884B2 (hu)
EP (1) EP1254146B1 (hu)
JP (1) JP2003516999A (hu)
KR (1) KR20020070991A (hu)
CN (2) CN1666991A (hu)
AT (1) ATE302786T1 (hu)
AU (1) AU783055B2 (hu)
CA (1) CA2395555A1 (hu)
CZ (1) CZ20021999A3 (hu)
DE (1) DE60022230T2 (hu)
ES (1) ES2244491T3 (hu)
HR (1) HRP20020522A2 (hu)
HU (1) HUP0204091A3 (hu)
IL (1) IL150227A0 (hu)
PL (1) PL364880A1 (hu)
PT (1) PT1254146E (hu)
RU (1) RU2002116232A (hu)
SK (1) SK8322002A3 (hu)
WO (1) WO2001044262A1 (hu)
YU (1) YU45602A (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2236023T3 (es) * 2000-01-11 2005-07-16 Teva Pharmaceutical Industries Ltd. Procedimiento para preparacion de polimorfos de claritromicina.
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
AU2001225787C1 (en) * 2000-02-29 2006-09-21 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
MXPA02009587A (es) * 2000-03-28 2003-05-14 Biochemie Gmbh Particulas granuladas con sabor enmascarado.
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP5686494B2 (ja) 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005061524A2 (en) * 2003-12-22 2005-07-07 Ranbaxy Laboratories Limited Process for the preparation of form ii clarithromycin
WO2005062898A2 (en) * 2003-12-24 2005-07-14 Advancis Pharmaceutical Corporation Enhanced absorption of modified release dosage forms
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US20070015719A1 (en) * 2005-07-07 2007-01-18 Elan Pharma International Limited Nanoparticulate clarithromycin formulations
WO2007036951A2 (en) * 2005-08-31 2007-04-05 Alembic Limited Process to obtain 6-o-methylerythromycin a (clarithromycin)_form ii
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
DE102007016367A1 (de) 2007-04-03 2008-10-09 Grünenthal GmbH Polymorph von Clarithromycin (Form V)
EP2030613A1 (en) 2007-08-17 2009-03-04 Abbott GmbH & Co. KG Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics
US9119769B2 (en) 2011-12-30 2015-09-01 The Curators Of The University Of Missouri Method for transforming pharmaceutical crystal forms
CN103087130B (zh) * 2013-02-06 2015-12-23 浙江国邦药业有限公司 一种克拉霉素晶型转换方法
MA39033A1 (fr) 2013-11-15 2017-11-30 Akebia Therapeutics Inc Formes solides d'acide {[5-(3-chlorophényl)-3-hydroxypyridine-2-carbonyl] amino}acétique, compositions et leurs utilisations

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4954572A (hu) * 1972-09-29 1974-05-27
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4660386A (en) * 1985-09-18 1987-04-28 Hansen John C Diagnostic system for detecting faulty sensors in liquid chiller air conditioning system
US4672056A (en) 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
US4640910A (en) 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
GB8721165D0 (en) 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
JP2751385B2 (ja) 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5274065A (en) * 1990-10-18 1993-12-28 Technical Development Associates Polyorganosiloxane-polyamide block copolymers
JPH0665080A (ja) * 1992-03-10 1994-03-08 Godo Shiyusei Kk α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食
US5756473A (en) 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5719272A (en) 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5837829A (en) 1996-04-02 1998-11-17 Abbott Laboratories 9-oximesilyl erythromycin a derivatives
US5808017A (en) 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
CA2261732C (en) 1996-07-29 2001-07-24 Abbott Laboratories Preparation of crystal form ii of clarithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5864023A (en) 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5852180A (en) 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
US5932710A (en) 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
US5892008A (en) 1997-12-16 1999-04-06 Abbott Laboratories Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
KR100377159B1 (ko) 1998-09-09 2003-08-19 한미약품공업 주식회사 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
AU4942800A (en) * 1999-06-11 2001-01-02 Ranbaxy Laboratories Limited Novel amorphous form of clarithromycin
ES2236023T3 (es) * 2000-01-11 2005-07-16 Teva Pharmaceutical Industries Ltd. Procedimiento para preparacion de polimorfos de claritromicina.
AU2001225787C1 (en) * 2000-02-29 2006-09-21 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
EP1254146A1 (en) 2002-11-06
DE60022230D1 (de) 2005-09-29
JP2003516999A (ja) 2003-05-20
US20020026038A1 (en) 2002-02-28
PT1254146E (pt) 2005-10-31
RU2002116232A (ru) 2004-01-10
ES2244491T3 (es) 2005-12-16
CA2395555A1 (en) 2001-06-21
YU45602A (sh) 2005-06-10
AU2431101A (en) 2001-06-25
EP1254146B1 (en) 2005-08-24
AU783055B2 (en) 2005-09-22
CN1217951C (zh) 2005-09-07
CN1434829A (zh) 2003-08-06
CZ20021999A3 (cs) 2003-02-12
US20040058879A1 (en) 2004-03-25
DE60022230T2 (de) 2006-01-26
WO2001044262A1 (en) 2001-06-21
HRP20020522A2 (en) 2004-12-31
HUP0204091A3 (en) 2003-05-28
IL150227A0 (en) 2002-12-01
SK8322002A3 (en) 2003-02-04
KR20020070991A (ko) 2002-09-11
ATE302786T1 (de) 2005-09-15
CN1666991A (zh) 2005-09-14
PL364880A1 (en) 2004-12-27
EP1254146A4 (en) 2003-04-16
US6599884B2 (en) 2003-07-29

Similar Documents

Publication Publication Date Title
HUP0204091A2 (hu) Eljárások a clarithromycin polimorf módosulatainak előállítására és az új polimorf IV módosulat, és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0204252A2 (hu) Eljárások a clarithromycin polimorf módosulatainak előállítására és ezeket tartalmazó gyógyszerkészítmények
PL392726A1 (pl) Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania
HUP0402043A2 (hu) Rimonabant polimorf formája, eljárás ezen forma előállítására és ilyen polimorf formát tartalmazó gyógyászati készítmények
NZ534374A (en) Method of synthesizing camptothecin-relating compounds
AP1709A (en) Ethanolate of azithromycin, process for manufacure, and pharmaceutical compositions thereof.
IL225002A (en) Aza-bicycloalkyl derivatives, processes for their preparation, pharmaceutical preparations containing them and their use as pharmaceuticals
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
CA2295515A1 (en) Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
WO1998042729A3 (de) Steroidsulfamate, verfahren zu ihrer herstellung und anwendung derselben
HK1070063A1 (en) Stable polymorph of flibanserin, technical processfor its preparation and the use thereof for prepa ring medicaments
HUP0202609A2 (hu) Rapamicinszármazékok regioszelektív előállítása
HUP0300701A2 (hu) Zolpidem hemitartarát, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
HUP0204012A2 (hu) Eljárás statinvegyületek kinyerésére fermentléből
SE9903291D0 (sv) New process
FI98067B (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
HUP9901616A1 (hu) Új benzofuranon-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
MXPA03012045A (es) Proceso para preparar derivados del acido 7-amino sin 3,5-dihidroxi heptanoico a traves de derivados del acido 6-ciano sin 3,5-dihidroxi hexanoico.
HUP0204069A2 (hu) Új eljárás leflunomid előállítására és a leflunomid új kristályformája és ezt tartalmazó gyógyszerkészítmény
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
GB0105335D0 (en) C2,8-disubstituted adenosine derivatives and their different uses
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
HUP0100019A2 (hu) A cipamfillin új polimorf formái, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE60108112D1 (de) Verfahren zur herstellung von carbostyril-derivaten

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees